List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 793 studies with search of:   "Preleukemia"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Terminated Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)
Conditions: Myelodysplastic Syndromes;   Leukemia, Myelomonocytic, Chronic;   Myelodysplasia;   Myelomonocytic
Interventions: Drug: Lonafarnib;   Other: Placebo
2 Active, not recruiting Decitabine in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: decitabine
3 Active, not recruiting Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: arsenic trioxide;   Drug: cholecalciferol
4 Completed Cholecalciferol in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Intervention: Drug: cholecalciferol
5 Recruiting Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: alemtuzumab;   Drug: arsenic trioxide;   Drug: azacitidine;   Drug: busulfan;   Drug: clofarabine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: fludarabine phosphate;   Drug: gemtuzumab ozogamicin;   Drug: melphalan;   Drug: tipifarnib;   Procedure: DNA methylation analysis;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: cytogenetic analysis;   Procedure: gene expression analysis;   Procedure: immunologic technique;   Procedure: laboratory biomarker analysis;   Procedure: mutation analysis;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation
6 Active, not recruiting Amifostine in Treating Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Intervention: Drug: amifostine trihydrate
7 Active, not recruiting Paricalcitol in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: paricalcitol
8 Active, not recruiting Biological Therapy in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: anti-thymocyte globulin;   Drug: etanercept
9 Active, not recruiting Lenalidomide in Treating Young Patients With Relapsed or Refractory Solid Tumors or Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: lenalidomide
10 Active, not recruiting Interleukin-2 in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Intervention: Drug: aldesleukin
11 Active, not recruiting Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Intervention: Drug: arsenic trioxide
12 Completed Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: bryostatin 1
13 Recruiting Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Drug: GM-K562 cell vaccine;   Procedure: cytogenetic analysis;   Procedure: flow cytometry;   Procedure: fluorescence in situ hybridization;   Procedure: immunoenzyme technique;   Procedure: laboratory biomarker analysis
14 Completed Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
Conditions: Cancer-Related Problem/Condition;   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Drug: epoetin alfa;   Drug: thalidomide
15 Not yet recruiting Everolimus in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Interventions: Drug: everolimus;   Procedure: flow cytometry;   Procedure: laboratory biomarker analysis;   Procedure: polymerase chain reaction
16 Recruiting PXD101 in Treating Patients With Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: belinostat
17 Completed Tipifarnib in Treating Patients With Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Intervention: Drug: tipifarnib
18 Recruiting Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: arsenic trioxide;   Drug: azacitidine
19 Suspended Azacitidine, Darbepoetin Alfa, and G-CSF in Treating Patients With Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: azacitidine;   Drug: darbepoetin alfa;   Drug: filgrastim;   Procedure: biopsy;   Procedure: flow cytometry;   Procedure: gene expression profiling;   Procedure: immunohistochemistry staining method
20 Active, not recruiting Gemtuzumab Ozogamicin, Fludarabine, and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: cyclosporine;   Drug: fludarabine phosphate;   Drug: gemtuzumab ozogamicin;   Drug: methotrexate;   Drug: mycophenolate mofetil;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: radiation therapy

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services